Opportunity Overview

The European Commission, through Horizon Europe, has announced a forthcoming funding opportunity aimed at improving the sustainable management of water, nutrients, and energy within African agricultural systems.

The call seeks research and innovation projects that develop, test

The European Commission has announced a forthcoming Horizon Europe funding opportunity aimed at accelerating the adoption, testing, validation, and deployment of Artificial Intelligence (AI) solutions in low- and middle-income countries, with a strong focus on strengthening AI innovation ecosystems

The European Commission has launched a Horizon Europe funding opportunity aimed at accelerating bio-based innovation through advanced biotechnology and biomanufacturing concepts. The call seeks to support research and innovation activities that strengthen Europe's bioeconomy while contributing to

The European Commission has announced a forthcoming Horizon Europe Cluster 1: Health funding opportunity aimed at accelerating the development of innovative antimicrobial therapies to combat antimicrobial-resistant (AMR) bacterial and fungal pathogens.

Antimicrobial resistance remains one of the most

Applications are now open for the Merck Research Grants 2026 programme, a global research funding initiative designed to support innovative scientific research with strong potential for future impact and industry collaboration.

Since 2018, Merck has awarded research grants to scientists and research

The Global Agriculture and Food Security Program (GAFSP) has launched its 9th Call for Proposals for Country-led Projects, providing approximately US$163 million in grant financing to support agriculture, food security, and climate resilience initiatives in some of the world’s poorest countries.

The

The Development Innovation Ventures (DIV) Fund is a global funding programme that supports innovative, evidence-based solutions with the potential to improve millions of lives. The fund operates as an R&D engine for development, combining risk-tolerant capital with rigorous evidence and scaling